TY  - CHAP
M1  - Book, Section
TI  - The Healthcare Technology Sectors
A1  - Burns, Lawton Robert
Y1  - 2021
N1  - 
T2  - The U.S. Healthcare Ecosystem: Payers, Providers, Producers
AB  - Perhaps  as  never  before,  countries  around  the  world  are  looking  at  biomedical  innovation  as  a  source  of  (1)  knowledge  creation  by  their  scientific  communities,  (2)  value  creation  for  their  populations,  and  (3)  wealth  creation  by  fostering  industries  and  expansion  of  employment.  In  the  United  States,  for  example,  bipartisan  passage  of  the  21st  Century  Cures  Act  (2016)  seeks  to  accelerate  new  product  development  and  faster  patient  access  to  new  treatments  and  therapies.  It  also  elevates  the  role  of  biomedical  research  through  an  additional  $6.3  billion  in  funding  for  the  National  Institutes  of  Health  (NIH)  and  other  agencies.  China’s  Twelfth  and  Thirteenth  Five-Year  Plans  (FYP  2011-2015,  2016-2020)  emphasize  a  shift  away  from  manufacturing  to  higher-end  technology  sectors  such  as  biotechnology,  biomedical  and  advanced  medical  equipment,  and  information  technology.  China  is  also  on  pace  to  surpass  the  United  States  in  terms  of  research  funding  levels,  indicating  biomedical  innovation  is  a  national  priority.1  
SN  - 
PB  - McGraw-Hill
CY  - New York, NY
Y2  - 2024/04/23
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1180254195
ER  -